Was Jim Cramer Right About Abbott Laboratories (ABT)?

By Yahoo! Finance   |   1 month ago
Was Jim Cramer Right About Abbott Laboratories (ABT)?

Jim Cramer was positive on Abbott Laboratories stock outlook back in 2024, advising to wait for a lower entry. The stock gained 28.54%, reflecting steady growth. ABT is rebounding with renewed investor interest in its healthcare products and diagnostics tools.

Read More

Did you find this insightful?